J&J tops 4Q earnings forecasts as profit, revenue slip

Category : Business

Unlocking Word Meanings

Read the following words/expressions found in today’s article.

  1. decline / dɪˈklaɪn / (v.) – to become lower in amount, number, etc.
    Example:

    Prices often go up when the economy declines.


  2. convert / kənˈvɜrt / (v.) – to change from one form, such as a currency or measurement, to another
    Example:

    Please convert the weight of the products into kilograms.


  3. exchange rate / ɪksˈtʃeɪndʒ reɪt / (n.) – the value of money in one country when changed into the money of another country
    Example:

    The US dollar to Japanese yen exchange rate increased today.


  4. split off (something) / splɪt ɔf / (phrasal v.) – for a part of an organization to separate from the organization and become independent
    Example:

    The tech giant announced that it will split off its business into three units.


  5. wind down (something) / waɪnd daʊn / (phrasal v.) – to gradually lessen the amount of work in a business or organization until it ends completely
    Example:

    In February, the company will wind down the production of winter clothes.


Article

Read the text below.

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue.


The healthcare giant also debuted a better-than-expected 2023 earnings forecast.


J&J said fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4.4% to $23.71 billion.


Sales were hurt last year by the strong U.S. dollar, which is currently worth more than a euro. That can affect companies with a lot of international business because they have to convert those sales into dollars when they report earnings.


J&J brings in nearly half of its revenue from outside the United States. The company’s international sales fell more than 11% in the quarter, but that decline was only 1% when not counting exchange rates.


J&J also recorded no U.S. sales in the quarter from its one-shot COVID-19 vaccine, which brought in $689 million in revenue from international markets. U.S. regulators have strictly limited who can receive J&J’s shot due to a small risk of rare but serious blood clots.


Johnson & Johnson sells prescription drugs and medical devices. It is splitting off its consumer health business, which includes well-known products like BandAids.


Chairman and CEO Joaquin Duato said that separation should be completed this year.


Revenue from pharmaceuticals, the company’s largest business, fell 7% to $13.16 billion in the fourth quarter even as worldwide sales of the cancer treatment Darzalex soared nearly 27% to more than $2 billion.


Medical device revenue slipped 1% to about $6.8 billion.


J&J also brought in $3.8 billion in sales from consumer health.


The company booked costs in the quarter from winding down COVID-19 vaccine production, splitting off consumer health, and completing its acquisition of cardiovascular technology company Abiomed, a deal it announced in November.


Overall, adjusted earnings totaled $2.35 per share in the fourth quarter.


Analysts expected earnings of $2.23 per share on $23.9 billion in revenue, according to FactSet.


This article was provided by The Associated Press.


Viewpoint Discussion

Enjoy a discussion with your tutor.

Discussion A

  • Nearly half of J&J’s revenue comes from outside the United States. What do you think J&J should do to generate more sales in the U.S. (ex. improve its products, create new products)? Discuss.
  • In your country, how popular are J&J products (ex. prescription drugs, health and beauty products)? Do you buy any of the company’s products? Why or why not? Discuss.

Discussion B

  • In the 4th quarter,  J&J recorded no US sales from its one-shot COVID-19 vaccine but generated $689 million in revenue from international markets. If you were one of J&J’s directors, would you decide to continue the production and sale of COVID-19 vaccines? Why or why not? Discuss.
  • US regulators have strictly limited who can receive J&J’s shot due to a small risk of rare but serious blood clots. If this vaccine was allowed in your country, would you have agreed to get vaccinated with it? Why or why not? Discuss.
Category : Business